Biological background of dermal substitutes

Burns

Volumn 36, Issue 3, 2010, Pages 305-321

  van der Veen, Vincent C ^a   van der Wal, Martijn B A ^a,b   van Leeuwen, Michiel C E ^a,b   Ulrich, Magda M W ^a,c   Middelkoop, Esther ^a,b,c  

^a Association of Dutch Burn Centers   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomaterials; Burn wound healing; Collagen; Dermal substitutes

Indexed keywords

BIOMATERIAL; COLLAGEN; GLYCOSAMINOGLYCAN; MATRIX METALLOPROTEINASE;

BIODEGRADATION; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CLINICAL TRIAL; DRUG STABILITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFECTION; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; SCAR FORMATION; SKIN DEFECT; SKIN GRAFT; SKINFOLD THICKNESS; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION; ANIMAL; ARTIFICIAL SKIN; BURNS; DISEASE MODEL; MATERIALS TESTING; PROCEDURES; SKIN TRANSPLANTATION; SWINE;

ANIMALS; BURNS; DISEASE MODELS, ANIMAL; HUMANS; MATERIALS TESTING; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; SUS SCROFA; TREATMENT OUTCOME; WOUND HEALING;

EID: 77649340788     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2009.07.012     Document Type: Review

References (174)

1. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 100 May (5) (1993) 721-725
2. Ehrlich H.P. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg 187 May (5A) (2004) 29S-33S
3. Teepe R.G., Kreis R.W., Koebrugge E.J., Kempenaar J.A., Vloemans A.F., Hermans R.P., et al. The use of cultured autologous epidermis in the treatment of extensive burn wounds. J Trauma 30 March (3) (1990) 269-275
4. Hansbrough J.F., and Franco E.S. Skin replacements. Clin Plast Surg 25 3 (1998 Jul) 407-423
5. Gallico III G.G., O'Connor N.E., Compton C.C., Kehinde O., and Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311 August (7) (1984) 448-451
6. Eldad A., Burt A., Clarke J.A., and Gusterson B. Cultured epithelium as a skin substitute. Burns Incl Therm Inj 13 3 (1987 Jun) 173-180
7. Rue III L.W., Cioffi W.G., McManus W.F., and Pruitt Jr. B.A. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma 34 May (5) (1993) 662-667 [discussion 7-8]
8. Herzog S.R., Meyer A., Woodley D., and Peterson H.D. Wound coverage with cultured autologous keratinocytes: use after burn wound excision, including biopsy follow up. J Trauma 28 February (2) (1988) 195-198
9. Clugston P.A., Snelling C.F., Macdonald I.B., Maledy H.L., Boyle J.C., Germann E., et al. Cultured epithelial autografts: three years of clinical experience with eighteen patients. J Burn Care Rehabil 12 November-December (6) (1991) 533-539
10. Desai M.H., Mlakar J.M., McCauley R.L., Abdullah K.M., Rutan R.L., Waymack J.P., et al. Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report. J Burn Care Rehabil 12 November-December (6) (1991) 540-545
11. Williamson J.S., Snelling C.F., Clugston P., Macdonald I.B., and Germann E. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma 39 August (2) (1995) 309-319
12. Rennekampff H.O., Kiessig V., and Hansbrough J.F. Current concepts in the development of cultured skin replacements. J Surg Res 62 May (2) (1996) 288-295
13. Hernon C.A.D.R., Freedlander E., Short R., Haddow D.B., Brotherston M., and MacNeil S. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med 1 6 (2006) 809-821
14. Hernon C.A., Harrison C.A., Thornton D.J., and MacNeil S. Enhancement of keratinocyte performance in the production of tissue-engineered skin using a low-calcium medium. Wound Repair Regen 15 September-October (5) (2007) 718-726
15. Coolen N.A., Verkerk M., Reijnen L., Vlig M., van den Bogaerdt A.J., Breetveld M., et al. Culture of keratinocytes for transplantation without the need of feeder layer cells. Cell Transpl 16 6 (2007) 649-661
16. Woodley D.T., Peterson H.D., Herzog S.R., Stricklin G.P., Burgeson R.E., Briggaman R.A., et al. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA 259 May (17) (1988) 2566-2571
17. Margolis D.J. The swings and roundabouts of randomized controlled studies in wound healing. Int J Low Extrem Wounds 3 March (1) (2004) 4-6
18. Wainwright D., Madden M., Luterman A., Hunt J., Monafo W., Heimbach D., et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 17 March-April (2) (1996) 124-136
19. Niezgoda J.A., Van Gils C.C., Frykberg R.G., and Hodde J.P. Randomized clinical trial comparing OASIS wound matrix to Regranex gel for diabetic ulcers. Adv Skin Wound Care 18 June (5 Pt 1) (2005) 258-266
20. Heimbach D., Luterman A., Burke J., Cram A., Herndon D., Hunt J., et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg 208 September (3) (1988) 313-320
21. van Zuijlen P.P., Vloemans J.F., van Trier A.J., Suijker M.H., van Unen E., Groenevelt F., et al. Dermal substitution in acute burns and reconstructive surgery: a subjective and objective long-term follow-up. Plastic Reconstruct Surg 108 December (7) (2001) 1938-1946
22. Hansbrough J.F., Mozingo D.W., Kealey G.P., Davis M., Gidner A., and Gentzkow G.D. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 18 January-February (1 Pt 1) (1997) 43-51
23. Van Dorp A.G., Verhoeven M.C., Koerten H.K., Van Der Nat-Van Der Meij T.H., Van Blitterswijk C.A., and Ponec M. Dermal regeneration in full-thickness wounds in Yucatan miniature pigs using a biodegradable copolymer. Wound Repair Regen 6 November-December (6) (1998) 556-568
24. Burke J.F., Yannas I.V., Quinby Jr. W.C., Bondoc C.C., and Jung W.K. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194 October (4) (1981) 413-428
25. Groos N., Guillot M., Zilliox R., and Braye F.M. Use of an artificial dermis (Integra) for the reconstruction of extensive burn scars in children. About 22 grafts. Eur J Pediatr Surg 15 June (3) (2005) 187-192
26. van Zuijlen P.P., van Trier A.J., Vloemans J.F., Groenevelt F., Kreis R.W., and Middelkoop E. Graft survival and effectiveness of dermal substitution in burns and reconstructive surgery in a one-stage grafting model. Plastic Reconstruct Surg 106 3 (2000 Sep) 615-623
27. Lineen E., and Namias N. Biologic dressing in burns. J Craniofacial Surg 19 July (4) (2008) 923-928
28. Whitaker I.S., Prowse S., and Potokar T.S. A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon. Annal Plastic Surg 60 March (3) (2008) 333-337
29. Yannas I.V., Burke J.F., Gordon P.L., Huang C., and Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14 March (2) (1980) 107-132
30. McKegney M., Taggart I., and Grant M.H. The influence of crosslinking agents and diamines on the pore size, morphology and the biological stability of collagen sponges and their effect on cell penetration through the sponge matrix. J Mater Sci Mater Med 12 September (9) (2001) 833-844
31. Nishi C., Nakajima N., and Ikada Y. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res 29 July (7) (1995) 829-834
32. Dagalakis N., Flink J., Stasikelis P., Burke J.F., and Yannas I.V. Design of an artificial skin. Part III. Control of pore structure. J Biomed Mater Res 14 July (4) (1980) 511-528
33. Suzuki S., Matsuda K., Isshiki N., Tamada Y., and Ikada Y. Experimental study of a newly developed bilayer artificial skin. Biomaterials 11 July (5) (1990) 356-360
34. Wang H., Pieper J., Peters F., van Blitterswijk C.A., and Lamme E.N. Synthetic scaffold morphology controls human dermal connective tissue formation. J Biomed Mater Res 74 September (4) (2005) 523-532
35. Lamme E.N., van Leeuwen R.T., Mekkes J.R., and Middelkoop E. Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen 10 May-June (3) (2002) 152-160
36. Yannas I.V., and Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14 January (1) (1980) 65-81
37. Hermans M.H. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns. Burns Incl Therm Inj 15 February (1) (1989) 57-59
38. Richters C.D., Hoekstra M.J., du Pont J.S., Kreis R.W., and Kamperdijk E.W. Immunology of skin transplantation. Clin Dermatol 23 July-August (4) (2005) 338-342
39. Richters C.D., Pirayesh A., Hoeksema H., Kamperdijk E.W., Kreis R.W., Dutrieux R.P., et al. Development of a dermal matrix from glycerol preserved allogeneic skin. Cell Tissue Bank 9 December (4) (2008) 309-315
40. Ghosh M.M., Boyce S., Layton C., Freedlander E., and Mac Neil S. A comparison of methodologies for the preparation of human epidermal-dermal composites. Annal Plastic Surg 39 October (4) (1997) 390-404
41. Ralston D.R., Layton C., Dalley A.J., Boyce S.G., Freedlander E., and Mac Neil S. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br J Dermatol 140 April (4) (1999) 605-615
42. Krejci N.C., Cuono C.B., Langdon R.C., and McGuire J. In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol 97 November (5) (1991) 843-848
43. Griffey E.S., and Liveley S.A. Production of an in vitro reconstituted skin using human neonatal foreskin keratinocytes (HFK) in combination with the dermal substrate AlloDerm. Presented at the congress on in vitro biology. May 20-24 (1995)
44. Livesey S.A., Herndon D.N., Hollyoak M.A., Atkinson Y.H., and Nag A. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation 60 July (1) (1995) 1-9
45. Sahota P.S., Burn J.L., Heaton M., Freedlander E., Suvarna S.K., Brown N.J., et al. Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen 11 July-August (4) (2003) 275-284
46. Branski L.K., Herndon D.N., Pereira C., Mlcak R.P., Celis M.M., Lee J.O., et al. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 35 November (11) (2007) 2615-2623
47. Peck M.D., Kessler M., Meyer A.A., and Bonham Morris P.A. A trial of the effectiveness of artificial dermis in the treatment of patients with burns greater than 45% total body surface area. J Trauma 52 May (5) (2002) 971-978
48. Haslik W., Kamolz L.P., Manna F., Hladik M., Rath T., and Frey M. Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm((R)). J Plast Reconstr Aesthet Surg (2008) 10.1016/j.bjps.2008.09.026
49. DeLustro F., Dasch J., Keefe J., and Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clinical orthopaedics and related research November (260) (1990) 263-279
50. Lynn A.K., Yannas I.V., and Bonfield W. Antigenicity and immunogenicity of collagen. J Biomed Mater Res B: Appl Biomater 71 November (2) (2004) 343-354
51. van der Flier A., and Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 305 September (3) (2001) 285-298
52. De Vries H.J., Mekkes J.R., Middelkoop E., Hinrichs W.L., Wildevuur C.R., and Westerhof W. Dermal substitutes for full-thickness wounds in a one-stage grafting model. Wound Repair Regen 1 October (4) (1993) 244-252
53. Middelkoop E., de Vries H.J., Ruuls L., Everts V., Wildevuur C.H., and Westerhof W. Adherence, proliferation and collagen turnover by human fibroblasts seeded into different types of collagen sponges. Cell Tissue Res 280 May (2) (1995) 447-453
54. Tomasek J.J., Haaksma C.J., Eddy R.J., and Vaughan M.B. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Rec 232 March (3) (1992) 359-368
55. Ehrlich H.P., Sun B., Kainth K.S., and Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen 14 September-October (5) (2006) 625-632
56. Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 85 April (3-4) (2006) 175-181
57. Desmouliere A., Chaponnier C., and Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13 January-February (1) (2005) 7-12
58. Aarabi S., Bhatt K.A., Shi Y., Paterno J., Chang E.I., Loh S.A., et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 21 October (12) (2007) 3250-3261
59. Emonard H., and Hornebeck W. Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation. Biol Chem 378 March-April (3-4) (1997) 265-271
60. de Vries H.J., Middelkoop E., Mekkes J.R., Dutrieux R.P., Wildevuur C.H., and Westerhof H. Dermal regeneration in native non-cross-linked collagen sponges with different extracellular matrix molecules. Wound Repair Regen 2 January (1) (1994) 37-47
61. Stern R., McPherson M., and Longaker M.T. Histologic study of artificial skin used in the treatment of full-thickness thermal injury. J Burn Care Rehabil 11 January-February (1) (1990) 7-13
62. Moiemen N.S., Staiano J.J., Ojeh N.O., Thway Y., and Frame J.D. Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plastic Reconstruct Surg 108 July (1) (2001) 93-103
63. Lamme E.N., de Vries H.J., van Veen H., Gabbiani G., Westerhof W., and Middelkoop E. Extracellular matrix characterization during healing of full-thickness wounds treated with a collagen/elastin dermal substitute shows improved skin regeneration in pigs. J Histochem Cytochem 44 November (11) (1996) 1311-1322
64. Hahnenberger R., and Jakobson A.M. Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane. Glycoconj J 8 August (4) (1991) 350-353
65. Luo H., Xu J., and Yu X. Isolation and bioactivity of an angiogenesis inhibitor extracted from the cartilage of Dasyatis akajei. Asia Pac J Clin Nutr 16 Suppl. 1 (2007) 286-289
66. Robinet A., Fahem A., Cauchard J.H., Huet E., Vincent L., Lorimier S., et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 118 January (Pt 2) (2005) 343-356
67. Tummalapalli C.M., and Tyagi S.C. Responses of vascular smooth muscle cell to extracellular matrix degradation. J Cell Biochem 75 December (3) (1999) 515-527
68. Blackwood K.A., McKean R., Canton I., Freeman C.O., Franklin K.L., Cole D., et al. Development of biodegradable electrospun scaffolds for dermal replacement. Biomaterials 29 July (21) (2008) 3091-3104
69. Powell H.M., and Boyce S.T. Engineered human skin fabricated using electrospun collagen-PCL blends: morphogenesis and mechanical properties. Tissue Eng Part A 15 8 (2009) 2177-2187
70. Cukierman E., Pankov R., Stevens D.R., and Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 294 November (5547) (2001) 1708-1712
71. Green J.A., and Yamada K.M. Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 59 November (13) (2007) 1293-1298
72. Shin H., Jo S., and Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials 24 November (24) (2003) 4353-4364
73. Hersel U., Dahmen C., and Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24 November (24) (2003) 4385-4415
74. Hern D.L., and Hubbell J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 39 February (2) (1998) 266-276
75. Zhou M., Smith A.M., Das A.K., Hodson N.W., Collins R.F., Ulijn R.V., et al. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 30 May (13) (2009) 2523-2530
76. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100 April (9) (2003) 5413-5418
77. Raeber G.P., Lutolf M.P., and Hubbell J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 89 August (2) (2005) 1374-1388
78. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160 January (2) (2003) 267-277
79. van Wachem P.B., van Luyn M.J., Nieuwenhuis P., Koerten H.K., Olde Damink L., Ten Hoopen H., et al. In vivo degradation of processed dermal sheep collagen evaluated with transmission electron microscopy. Biomaterials 12 March (2) (1991) 215-223
80. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 20 April (2) (2008) 86-100
81. Coolen N.A., Vlig M., van den Bogaerdt A.J., Middelkoop E., and Ulrich M.M. Development of an in vitro burn wound model. Wound Repair Regen 16 July-August (4) (2008) 559-567
82. Paul Ehrlich H., Sun B., Kainth K.S., and Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen 14 September-October (5) (2006) 625-632
83. Boelsma E., Verhoeven M.C., and Ponec M. Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J Invest Dermatol 112 April (4) (1999) 489-498
84. Tjabringa G., Bergers M., van Rens D., de Boer R., Lamme E., and Schalkwijk J. Development and validation of human psoriatic skin equivalents. Am J Pathol 173 September (3) (2008) 815-823
85. Ghahary A., and Ghaffari A. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar. Wound Repair Regen 15 September-October (Suppl. 1) (2007) S46-S53
86. El-Ghalbzouri A., Gibbs S., Lamme E., Van Blitterswijk C.A., and Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 147 August (2) (2002) 230-243
87. El Ghalbzouri A., Lamme E., and Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 310 November (2) (2002) 189-199
88. Aoki S., Toda S., Ando T., and Sugihara H. Bone marrow stromal cells, preadipocytes, and dermal fibroblasts promote epidermal regeneration in their distinctive fashions. Mol Biol Cell 15 October (10) (2004) 4647-4657
89. Davidson J.M. Animal models for wound repair. Arch Dermatol Res 290 July (Suppl.) (1998) S1-S11
90. Kyriakides T.R., and Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thrombos Haemostas 90 December (6) (2003) 986-992
91. Beumer G.J., van Blitterswijk C.A., and Ponec M. Degradative behaviour of polymeric matrices in (sub)dermal and muscle tissue of the rat: a quantitative study. Biomaterials 15 June (7) (1994) 551-559
92. Druecke D., Lamme E.N., Hermann S., Pieper J., May P.S., Steinau H.U., et al. Modulation of scar tissue formation using different dermal regeneration templates in the treatment of experimental full-thickness wounds. Wound Repair Regen 12 September-October (5) (2004) 518-527
93. Middelkoop E., van den Bogaerdt A.J., Lamme E.N., Hoekstra M.J., Brandsma K., and Ulrich M.M. Porcine wound models for skin substitution and burn treatment. Biomaterials 25 April (9) (2004) 1559-1567
94. Lindblad W.J. Considerations for selecting the correct animal model for dermal wound-healing studies. J Biomater Sci 19 8 (2008) 1087-1096
95. Ehrlich H.P., and Needle A.L. Wound healing in tight-skin mice: delayed closure of excised wounds. Plastic Reconstruct Surg 72 August (2) (1983) 190-198
96. Galiano R.D., Michaels J., Dobryansky M., Levine J.P., and Gurtner G.C. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12 July-August (4) (2004) 485-492
97. Sullivan T.P., Eaglstein W.H., Davis S.C., and Mertz P. The pig as a model for human wound healing. Wound Repair Regen 9 March-April (2) (2001) 66-76
98. Gross J., Farinelli W., Sadow P., Anderson R., and Bruns R. On the mechanism of skin wound "contraction": a granulation tissue "knockout" with a normal phenotype. Proc Natl Acad Sci USA 92 June (13) (1995) 5982-5986
99. Hinrichsen N., Birk-Sorensen L., Gottrup F., and Hjortdal V. Wound contraction in an experimental porcine model. Scand J Plastic Reconstruct Surg Hand Surg Nordisk plastikkirurgisk forening [and] Nordisk klubb for handkirurgi 32 September (3) (1998) 243-248
100. Reid M.J., Currie L.J., James S.E., and Sharpe J.R. Effect of artificial dermal substitute, cultured keratinocytes and split thickness skin graft on wound contraction. Wound Repair Regen 15 November-December (6) (2007) 889-896
101. Varma M.J., Breuls R.G., Schouten T.E., Jurgens W.J., Bontkes H.J., Schuurhuis G.J., et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Develop 16 February (1) (2007) 91-104
102. van den Bogaerdt A.J., van Zuijlen P.P., van Galen M., Lamme E.N., and Middelkoop E. The suitability of cells from different tissues for use in tissue-engineered skin substitutes. Arch Dermatol Res 294 May (3) (2002) 135-142
103. Ramos M.L., Gragnani A., and Ferreira L.M. Is there an ideal animal model to study hypertrophic scarring?. J Burn Care Res 29 March-April (2) (2008) 363-368
104. Bello Y.M., Falabella A.F., and Eaglstein W.H. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2 5 (2001) 305-313
105. Jones I., Currie L., and Martin R. A guide to biological skin substitutes. Br J Plast Surg 55 April (3) (2002) 185-193
106. Ruszczak Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55 November (12) (2003) 1595-1611
107. Clark R.A., Ghosh K., and Tonnesen M.G. Tissue engineering for cutaneous wounds. J Invest Dermatol 127 May (5) (2007) 1018-1029
108. Pham C., Greenwood J., Cleland H., Woodruff P., and Maddern G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 33 December (8) (2007) 946-957
109. Boyce S.T., and Warden G.D. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 183 April (4) (2002) 445-456
110. Powers P.S., Sarkar S., Goldgof D.B., Cruse C.W., and Tsap L.V. Scar assessment: current problems and future solutions. J Burn Care Rehabil 20 January-February (1 Pt 1) (1999) 54-60 [discussion 53]
111. Bond J.S., Duncan J.A., Sattar A., Boanas A., Mason T., O'Kane S., et al. Maturation of the human scar: an observational study. Plastic Reconstruct Surg 121 May (5) (2008) 1650-1658
112. van Zuijlen P.P., Angeles A.P., Kreis R.W., Bos K.E., and Middelkoop E. Scar assessment tools: implications for current research. Plastic Reconstruct Surg 109 March (3) (2002) 1108-1122
113. Sullivan T., Smith J., Kermode J., McIver E., and Courtemanche D.J. Rating the burn scar. J Burn Care Rehabil 11 May-June (3) (1990) 256-260
114. Beausang E., Floyd H., Dunn K.W., Orton C.I., and Ferguson M.W. A new quantitative scale for clinical scar assessment. Plastic Reconstruct Surg 102 November (6) (1998) 1954-1961
115. Draaijers L.J., Tempelman F.R., Botman Y.A., Tuinebreijer W.E., Middelkoop E., Kreis R.W., et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plastic Reconstruct Surg 113 June (7) (2004) 1960-1965 [discussion 6-7]
116. van de Kar A.L., Corion L.U., Smeulders M.J., Draaijers L.J., van der Horst C.M., and van Zuijlen P.P. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plastic Reconstruct Surg 116 August (2) (2005) 514-522
117. Draaijers L.J., Tempelman F.R., Botman Y.A., Kreis R.W., Middelkoop E., and van Zuijlen P.P. Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation?. Burns 30 March (2) (2004) 103-107
118. Oliveira G.V., Chinkes D., Mitchell C., Oliveras G., Hawkins H.K., and Herndon D.N. Objective assessment of burn scar vascularity, erythema, pliability, thickness, and planimetry. Dermatol Surg 31 January (1) (2005) 48-58
119. Nedelec B., Correa J.A., Rachelska G., Armour A., and LaSalle L. Quantitative measurement of hypertrophic scar: intrarater reliability, sensitivity, and specificity. J Burn Care Res 29 May-June (3) (2008) 489-500
120. Nedelec B., Correa J.A., Rachelska G., Armour A., and LaSalle L. Quantitative measurement of hypertrophic scar: interrater reliability and concurrent validity. J Burn Care Res 29 May-June (3) (2008) 501-511
121. Lau J.C., Li-Tsang C.W., and Zheng Y.P. Application of tissue ultrasound palpation system (TUPS) in objective scar evaluation. Burns 31 June (4) (2005) 445-452
122. Du Y.C., Lin C.M., Chen Y.F., Chen C.L., and Chen T. Implementation of a burn scar assessment system by ultrasound techniques. Conf Proc IEEE Eng Med Biol Soc 1 (2006) 2328-2331
123. Friedman P.M., Skover G.R., Payonk G., Kauvar A.N., and Geronemus R.G. 3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg 28 March (3) (2002) 199-204
124. Lagarde J.M., Rouvrais C., Black D., Diridollou S., and Gall Y. Skin topography measurement by interference fringe projection: a technical validation. Skin Res Technol 7 May (2) (2001) 112-121
125. Saur R., Schramm U., Steinhoff R., and Wolff H.H. Structure analysis of the skin surface using computer-assisted laser profilometry. New method for the quantitative assessment of roughness structure of the skin. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 42 August (8) (1991) 499-506
126. Fong S.S., Hung L.K., and Cheng J.C. The cutometer and ultrasonography in the assessment of postburn hypertrophic scar-a preliminary study. Burns 23 March (Suppl. 1) (1997) S12-S18
127. Draaijers L.J., Botman Y.A., Tempelman F.R., Kreis R.W., Middelkoop E., and van Zuijlen P.P. Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns 30 March (2) (2004) 109-114
128. Boyce S.T., Supp A.P., Wickett R.R., Hoath S.B., and Warden G.D. Assessment with the dermal torque meter of skin pliability after treatment of burns with cultured skin substitutes. J Burn Care Rehabil 21 January-February (1 Pt 1) (2000) 55-63
129. Wysocki A.B. Wound measurement. Int J Dermatol 35 February (2) (1996) 82-91
130. Wainwright D.J. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 21 June (4) (1995) 243-248
131. Jung S.N., Chung J.W., Yim Y.M., and Kwon H. One-stage skin grafting of the exposed skull with acellular human dermis (AlloDerm). J Craniofacial Surg 19 November (6) (2008) 1660-1662
132. Barret J.P., Dziewulski P., McCauley R.L., Herndon D.N., and Desai M.H. Dural reconstruction of a class IV calvarial burn with decellularized human dermis. Burns 25 August (5) (1999) 459-462
133. Lattari V., Jones L.M., Varcelotti J.R., Latenser B.A., Sherman H.F., and Barrette R.R. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil 18 March-April (2) (1997) 147-155
134. de Moya M.A., Dunham M., Inaba K., Bahouth H., Alam H.B., Sultan B., et al. Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen. J Trauma 65 August (2) (2008) 349-353
135. Becker S., Saint-Cyr M., Wong C., Dauwe P., Nagarkar P., Thornton J.F., et al. AlloDerm versus DermaMatrix in immediate expander-based breast reconstruction: a preliminary comparison of complication profiles and material compliance. Plastic Reconstruct Surg 123 January (1) (2009) 1-6 [discussion 107-8]
136. Barber F.A., Herbert M.A., and Coons D.A. Tendon augmentation grafts: biomechanical failure loads and failure patterns. Arthroscopy 22 May (5) (2006) 534-538
137. Brigido S.A., Boc S.F., and Lopez R.C. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics 27 January (Suppl. 1) (2004) s145-s149
138. Brigido S.A. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 3 September (3) (2006) 181-187
139. Martin B.R., Sangalang M., Wu S., and Armstrong D.G. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. Int Wound J 2 June (2) (2005) 161-165
140. Mostow E.N., Haraway G.D., Dalsing M., Hodde J.P., and King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41 May (5) (2005) 837-843
141. Romanelli M., Dini V., Bertone M., Barbanera S., and Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 4 March (1) (2007) 3-7
142. Benbow M. Oasis: an innovative alternative dressing for chronic wounds. Br J Nurs 10 22 (2002) 1489-1492
143. Gibbs S., van den Hoogenband H.M., Kirtschig G., Richters C.D., Spiekstra S.W., Breetveld M., et al. Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol 155 August (2) (2006) 267-274
144. Waymack P., Duff R.G., and Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns 26 November (7) (2000) 609-619
145. Parenteau N.L., Nolte C.M., Bilbo P., Rosenberg M., Wilkins L.M., Johnson E.W., et al. Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 45 March (3) (1991) 245-251
146. Donohue K.G., Carson P., Iriondo M., Zhou L., Saap L., Gibson K., et al. Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds. J Dermatol 32 August (8) (2005) 626-631
147. Falanga V., and Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7 July-August (4) (1999) 201-207
148. Falanga V., Margolis D., Alvarez O., Auletta M., Maggiacomo F., Altman M., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 134 March (3) (1998) 293-300
149. Veves A., Falanga V., Armstrong D.G., and Sabolinski M.L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24 February (2) (2001) 290-295
150. Muhart M., McFalls S., Kirsner R.S., Elgart G.W., Kerdel F., Sabolinski M.L., et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol 135 August (8) (1999) 913-918
151. Sabolinski M.L., Alvarez O., Auletta M., Mulder G., and Parenteau N.L. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers. Biomaterials 17 February (3) (1996) 311-320
152. Eaglstein W.H., Alvarez O.M., Auletta M., Leffel D., Rogers G.S., Zitelli J.A., et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg 25 March (3) (1999) 195-201
153. Shealy Jr. F.G., and DeLoach E.D. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting. Adv Skin Wound Care 19 July-August (6) (2006) 310-322
154. Gohari S., Gambla C., Healey M., Spaulding G., Gordon K.B., Swan J., et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg 28 December (12) (2002) 1107-1114 [discussion 14]
155. Falabella A.F., Schachner L.A., Valencia I.C., and Eaglstein W.H. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol 135 October (10) (1999) 1219-1222
156. Falabella A.F., Valencia I.C., Eaglstein W.H., and Schachner L.A. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 136 October (10) (2000) 1225-1230
157. Martin L.K., and Kirsner R.S. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol 42 May (5) (2003) 402-404
158. Ozerdem O.R., Wolfe S.A., and Marshall D. Use of skin substitutes in pediatric patients. J Craniofacial Surg 14 July (4) (2003) 517-520
159. Stark H.J., Boehnke K., Mirancea N., Willhauck M.J., Pavesio A., Fusenig N.E., et al. Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J Invest Dermat Sympos Proc/Soc Invest Dermat Inc 11 September (1) (2006) 93-105
160. Zacchi V., Soranzo C., Cortivo R., Radice M., Brun P., and Abatangelo G. In vitro engineering of human skin-like tissue. J Biomed Mater Res 40 May (2) (1998) 187-194
161. Tamisani A.M. The use of Hyalomatrix in deep paediatric burns. Annal Burns Fire Disasters XVII December (2004) 4
162. Gravante G., Delogu D., Giordan N., Morano G., Montone A., and Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res 28 March-April (2) (2007) 269-274
163. Heimbach D.M., Warden G.D., Luterman A., Jordan M.H., Ozobia N., Ryan C.M., et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 24 January-February (1) (2003) 42-48
164. Dantzer E., and Braye F.M. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 54 December (8) (2001) 659-664
165. Campitiello E., Della Corte A., Fattopace A., D'Acunzi D., and Canonico S. The use of artificial dermis in the treatment of chronic and acute wounds: regeneration of dermis and wound healing. Acta Biomed 76 Suppl. 1 (2005) 69-71
166. Verolino P., Casoli V., Masia D., Delia G., Isacu C., and Castede J.C. A skin substitute (Integra) in a successful delayed reconstruction of a severe injured hand. Burns 34 March (2) (2008) 284-287
167. Ryssel H., Gazyakan E., Germann G., and Ohlbauer M. The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns-a pilot study. Burns 34 February (1) (2008) 93-97
168. Haslik W., Kamolz L.P., Nathschlager G., Andel H., Meissl G., and Frey M. First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 33 May (3) (2007) 364-368
169. Still J., Glat P., Silverstein P., Griswold J., and Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29 December (8) (2003) 837-841
170. Eisenberg M., and Llewelyn D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts. Br J Plast Surg 51 December (8) (1998) 608-613
171. Cooper M.L., Hansbrough J.F., Spielvogel R.L., Cohen R., Bartel R.L., and Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12 March (2) (1991) 243-248
172. Gentzkow G.D., Iwasaki S.D., Hershon K.S., Mengel M., Prendergast J.J., Ricotta J.J., et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19 April (4) (1996) 350-354
173. Naughton G., Mansbridge J., and Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 21 November (11) (1997) 1203-1210
174. Beumer G.J., van Blitterswijk C.A., Bakker D., and Ponec M. A new biodegradable matrix as part of a cell seeded skin substitute for the treatment of deep skin defects: a physico-chemical characterisation. Clin Mater 14 1 (1993) 21-27